The MarketWatch News Department was not involved in the creation of this content. SEATTLE, March 10, 2026 /PRNewswire/ -- CounterX Therapeutics, a biotechnology company focused on developing novel ...

Learn how BeSEC enables precise analysis of antibody aggregation and molecular weight through dual-angle light scattering.

A Study shows mutation-resistant antibodies with 269×affinity, a proof point for CEPI’s 100 Days Mission and closing ...

Invivyd, Inc. (NASDAQ:IVVD) Q4 2025 Earnings Call Transcript March 5, 2026 Invivyd, Inc. misses on earnings expectations. Reported EPS is $-0.06428 EPS, expectations were $-0.06. Operator: Good day, ...

The political and scientific fight over the COVID vaccines rages on, years later, with the belated acknowledgment by the FDA ...

Commentary: While vaccines stimulate the body to produce an immune response, monoclonal antibodies skip a few steps and infuse antibodies directly.

The political and scientific fight over the COVID vaccines rages on, years later, with the belated acknowledgment by the FDA there were likely a small number of children killed by ...

Modernizing biomanufacturing methods and reducing regulatory burdens are key landmarks on India’s roadmap for expanding biosimilars development.

This clinical-stage biotech develops antibody therapeutics targeting cancer, with a pipeline focused on oncology and immunotherapy markets.

BioAtla has engaged Tungsten Advisors as the Company’s exclusive strategic financial advisor. There can be no assurance that this process will result in any such transaction. BioAtla does not intend ...

The heavy use of technology in K-12 schools—from 1-to-1 computing programs to artificial intelligence —is causing some policymakers and parents to call for educators to dial back their use of ...

Antibody discovery is a critical engine of modern drug development, powering therapies for cancer, autoimmune diseases, and infectious disorders. For decades, discovery relied on traditional ...